Intraventricular encapsulated calf adrenal chromaffin cells: Viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats

Restorative Neurology and Neuroscience

Volumn 11, Issue 1-2, 1997, Pages 21-35

  Lindner, Mark D ^a   Plone, Melissa A ^a   Frydel, Beata ^a   Kaplan, Faith A ^a   Krueger, Paula M ^a   Bell, William J ^a   Blaney, Thomas J ^a   Winn, Shelley R ^a   Sherman, Sandy S ^a   Doherty, Edward J ^a   Emerich, Dwaine F ^a  

^a CytoTherapeutics Inc   (United States)

Author keywords

Adrenal chromaffin cells; Adverse effects; Safety; Side effect profile; Toxicity

Indexed keywords

CATECHOLAMINE; METENKEPHALIN; MORPHINE; NICOTINE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CATTLE; CHROMAFFIN CELL; CHRONIC PAIN; COGNITION; CONTROLLED STUDY; HOT PLATE TEST; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; XENOGRAFT;

EID: 0030916070     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: 10.3233/rnn-1997-111203     Document Type: Article

References (63)

1. Aebischer, P., Buchser, E., Joseph, J.M., Favre, J., De Tribolet, N., Lysaght, M., Rudnick, S. and Goddard, M., Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: a preliminary report, Transplantation, 58 (1994) 1275-1277.
2. Arner, S. and Meyerson, B.A., Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain, 33 (1988) 11-23.
3. Bruera, E., Franco, J.J., Maltoni, M., Watanabe, S. and Suarezalmazor, M., Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation, J. Pain Symptom Manage., 10 (1995) 287-291.
4. Bruera, E., Macmillan, K., Hanson, J. and MacDonald, R.N., The cognitive effects of the administration of narcotic analgesics in patients with cancer pain, Pain, 39 (1989) 13-16.
5. Coda, B.A., Hill, H.F., Hunt, E.B., Kerr, E.B., Jacobson, R.C. and Chapman, C.R., Cognitive and motor function impairments during continuous opioid analgesic infusions, Hum. Psychopharmacol. Clin. Exp., 8(6) (1993) 383-400.
6. Cook, D.J. and Scornik, J.C., Flow cytometry crossmatch. In D.L. Phelan, E.M. Mickelson, H.S. Noreen, T.W. Shroyer, D.M. Cluff and A. Nikaein (Eds.), American Society for Histompatibility and Immunogenetics: Laboratory Manual. Vol. 3, ASHI, Lenexa, KS, 1993, pp. V.3.1-V.3.7.
7. Czech, K.A. and Sagen, J., Update on cellular transplantation into the CNS as a novel therapy for chronic pain, Prog. Neurobiol., 46 (1995) 507-529.
8. Date, I., Asari, S. and Ohmoto, T., Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report, Neurosurgery, 37 (1995) 515-518.
9. Dodd, D.H. and Schultz, R.F., Jr., Computational procedures for estimating magnitude of effect for some analysis of variance designs, Psychol. Bull., 79(6) (1973) 391-395.
10. Dunnett, S.B., Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats, Psychopharmacology (Berl.), 87 (1985) 357-363.
11. Emerich, D.F., McDermott, P.E., Krueger, P.M., Frydel, B., Sanberg, P.R. and Winn, S.R., Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats, Exp. Neurol., 122 (1993) 37-47.
12. Goetz, C.G., Stebbins, G.T. and Klawans, H.L. United Parkinson foundation neurotransplantation registry: multicenter US and Canadian data base, presurgical and 12 month follow-up, 1990, pp. 611-617.
13. Hama, A.T. and Sagen, J., Induction of spinal NADPH-diaphorase by nerve injury is attenuated by adrenal medullary transplants. Brain Res., 640 (1994) 345-351.
14. Hama, A.T. and Sagen, J., Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space, Brain Res., 651 (1994) 183-193.
15. Hanks, G.W., Opioid-responsive and opioid-non-responsive pain in cancer, Br. Med. Bull., 47 (1991) 718-731.
16. Izquierdo, I., Effect of naloxone and morphine on various forms of memory in the rat: possible role of endogenous opiate mechanisms in memory consolidation, Psychopharmacohgy, 66 (1979) 199-203.
17. Izquierdo, I., Dias, R.D., Souza, D.O., Carrasco, M.A., Elisabetsky, E. and Perry, M.L., The role of opioid peptides in memory and learning, Behav. Brain Res., 1 (1980) 451-468.
18. Izquierdo, I., Paiva, A.C.M. and Elisabetsky, E., Post-training intraperitoneal administration of leu-enkephalin and β-endorphin causes retrograde amnesia for two different tasks in rats, Behav. Neural Biol., 28 (1980) 246-250.
19. Joseph, J.M., Goddard, M.B., Mills, J., Padrun, V., Zurn, A., Zielinski, B., Favre, J., Gardaz, J.P., Mosimann, F., Sagen, J., Christenson, L. and Aebischer, P., Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain, Cell Transplant., 3(5) (1994) 355-364.
20. Kaplan, F.A., Krueger, P.M., Harvey, J. and Goddard, M.B., Peripheral xenogeneic immunological response to encapsulated bovine adrenal chromaffin cells implanted within the sheep lumbar intrathecal space, Transplantation, 61 (1996) 1215-1221.
21. Kapp, B.S. and Gallagher, M., Opiates and memory, Trends Neurosci., 2 (1979) 177-180.
22. Kerr, B., Hill, H., Coda, B., Calogero, M., Chapman, C.R., Hunt, E., Buffington, V. and Mackie, A., Concentration-related effects of morphine on cognition and motor control in human subjects, Neuropsychopharmacology, 5 (1991) 157-166.
23. Kirk, R.E., Experimental Design: Procedures for the Behavioral Sciences. Brooks/Cole Publishing Company, Pacific Grove, CA, 1982,
24. Laties, V.G., Schedule-controlled operant behavior during the hazard identification stage of neurotoxicity risk assessment. In B. Weiss and J.L. Odonoghue (Eds.), Neurobehavioral Toxicity: Anaylsis and Interpretation, Raven Press, NY, 1994, pp. 253-262.
25. Meert, T.F. and Dekock, M., Potentiation of the analgesic properties of fentanyl-like opioids with alpha(2)-adrenoceptor agonists in rats, Anesthesiology, 81(3) (1994) 677-688.
26. Messing, R.B., Jensen, R.A., Martinez, J.L., Jr., Spiehler, V.R., Vasquez, B.J., Soumireu-Mourat, B., Liang, K.C. and McGaugh, J.L., Naloxone enhancement of memory, Behav. Neural Biol., 27 (1979) 266-275.
27. Olanow, C.W., Koller, W., Goetz, C.G., Stebbins, G.T., Cahill, D.W., Gauger, L.L., Morantz, R., Penn, R.D., Tanner, C.M., Klawans, H.L., Shannon, K.M., Comella, C.L. and Witt, T., Autologous tranplantation of adrenal medulla in Parkinson's disease: 18-month results, Arch. Neurol., 47 (1990) 1286-1289.
28. Ortega, J.D., Sagen, J. and Pappas, G.D., Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS, Cell Transplant., 1 (1992) 33-41.
29. Ortega, J.D., Sagen, J. and Pappas, G.D., Survival and integration of bovine chromaffin cells transplanted into rat central nervous system without exogenous trophic factors, J. Comp. Neurol., 323 (1992) 13-24.
30. Ortegaalvaro, A., Gibertrahola, J., Chover, A.J., Tejedorreal, P., Casas, J. and Mico, J.A., Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain, Exp. Neurol., 130 (1994) 9-14.
31. Pappas, G.D. and Sagen, J. Morphological correlates of chromaffin cell transplants in CNS pain modulatory regions. In Tissue Engineering, Alan R. Liss, New York, 1988, pp. 289-294.
32. Penn, R.D. and Paice, J.A., Chronic intrathecal morphine for intractable pain, J. Neurosurg., 67 (1987) 182-186.
33. Plone, M.A., Emerich, D.F. and Lindner, M.D., Individual differences in the hotplate test and effects of habituation on sensitivity to morphine, Pain, 66 (1996) 265-270.
34. Sagen, J., Chromaffin cell transplants for alleviation of chronic pain, ASAIO J., 38 (1992) 24-28.
35. Sagen, J., Kemmler, J.E. and Wang, H., Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity, J. Neurochem., 56 (1991) 623-627.
36. Sagen, J. and Pappas, G.D., Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions, Exp. Neurol., 102 (1988) 290-297.
37. Sagen, J., Pappas, G.D. and Ortega, J.D., Host-graft relationships of isolated bovine chromaffin cells in rat periaqueductal grey, J. Neurocytol., 19 (1990) 697-707.
38. Sagen, J., Pappas, G.D. and Perlow, M.J., Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity, Brain Res., 384 (1986) 189-194.
39. Sagen, J., Pappas, G.D. and Pollard, H.B., Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord, Proc. Natl. Acad. Sci. USA, 83 (1986) 7522-7526.
40. Sagen, J., Pappas, G.D. and Winnie, A.P., Alleviation of pain in cancer patients by adrenal medullary transplants in the spinal subarachnoid space, Cell Transplant., 2 (1993) 259-266.
41. Sagen, J. and Wang, H., Adrenal medullary grafts suppress c-fos induction in spinal neurons of arthritic rats, Neurosci. Lett., 192 (1995) 181-184.
42. Sagen, J., Wang, H. and Pappas, G.D., Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model, Pain, 42 (1990) 69-79.
43. Sagen, J., Wang, H., Tresco, P.A. and Aebischer, P., Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances, J. Neurosci., 13 (1993) 2415-2423.
44. Sala, M., Braida, D., Leone, M.P., Calcaterra, P., Frattola, D. and Gori, E., Chronic morphine affects working memory during treatment and withdrawal in rats: Possible residual long-term impairment, Behav. Pharmacol., 5 (1994) 570-580.
45. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition, Vol. 1, SAS Institute Inc. Cary, North Carolina, 1989,
46. Schueler, S.B., Sagen, J., Pappas, G.D. and Kordower, J.H., Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation, Cell Transplant., 4 (1995) 55-64.
47. Schug, S.A., Zech, D., Grond, S., Jung, H., Meuser, T. and Stobbe, B., A long-term survey of morphine in cancer pain patients, J. Pain Symptom. Manage., 7 (1992) 259-266.
48. Siegan, J.B. and Sagen, J., Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants, Brain Res., 680 (1995) 88-98.
49. Stanhope, K.J., Mclenachan, A.P. and Dourish, C.T., Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: Effects of scopolamine, 8-OHDPAT and EAA antagonists, Psychopharmacology, 122 (1995) 268-280.
50. Stromberg, I., Herrera-Marschitz, M., Ungerstedt, U., Ebendal, T. and Olson, L., Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior, Exp. Brain Res., 60 (1985) 335-349.
51. Tan, S.A. and Aebischer, P. The problems of delivering neuroactive molecules to the CNS. In G.R. Bock and J.A. Goode (Eds.), Growth Factors as Drugs for Neurological and Sensory Disorders, Wiley, Chichester, 1996, pp. 211-236.
52. Tresco, P.A., Winn, S.R., Tan, S., Jaeger, C.B., Greene, L.A. and Aebischer, P., Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior, Cell Transplant., 1 (1992) 255-264.
53. Tsuneto, S., Hayashi, A., Miyazaki, M. and Kashiwagi, T., A clinical survey of controlled-release morphine sulphate for cancer pain relief in a Japanese hospice, Postgrad. Med. J., 67(2) (1991) S79-S81.
54. Vaquero, J., Arias, A., Oya, S. and Zurita, M., Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats, NeuroReport, 2 (1991) 149-151.
55. Wang, H. and Sagen, J., Optimization of adrenal medullary allograft conditions for pain alleviation, J. Neural Transplant. Plast., 5 (1994) 49-64.
56. Wang, H. and Sagen, J., Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord, Neuropharmacology, 33 (1994) 681-692.
57. Winn, S.R., Tresco, P.A., Zielinski, B., Greene, L.A., Jaeger, C.B. and Aebischer, P., Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells, Exp. Neurol., 113 (1991) 322-329.
58. Winnie, A.P., Pappas, G.D., Gupta, T.K., Wang, H., Ortega, J.D. and Sagen, J., Subarachnoid adrenal medullary transplants for terminal cancer pain: a report of preliminary studies, Anesthesiology, 79 (1993) 644-653.
59. Yaksh, T.L. and Reddy, S.V.R., Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen, Anesthesiology, 54 (1981) 451-467.
60. Young, I.T., Proof without prejudice: use of the Kolmogorov-Smirnoc Test for the analysis of histograms from flow systems and other sources, J. Histochem. Cytochem., 49 (1977) 935-941.
61. Zenz, M., Strumpf, M. and Tryba, M., Long-term oral opioid therapy in patients with chronic nonmalignant pain, J. Pain Symptom Manage., 7 (1992) 69-77.
62. Zhukovsky, D.S., Gorowski, E., Hausdorff, J., Napolitano, B. and Lesser, M., Unmet analgesic needs in cancer patients, J. Pain Symptom Manage., 10 (1995) 113-119.
63. Zimmermann, M., Ethical guidelines for investigators of experimental pain in conscious animals, Pain, 16 (1983) 109-110.